Weight Loss, Food and Drug Administration

How Much Should Weight Loss Drugs Cost?
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
Here’s why Ozempic maker’s new weight-loss drug isn’t good enough for investors
New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
Weight Loss Drug Will Be Offered for $499 a Month for Some Patients
Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.
Who can get weight loss drugs on the NHS in Scotland?
Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News has established. Medications like Mounjaro and Wegovy have been hailed as "game changers" for tackling obesity.
The State of Weight Loss Drugs
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo Nordisk and Eli Lilly are actually undervalued.
FBI warns about counterfeit weight loss drugs
The FBI is warning about counterfeit weight loss drugs being sold that claim to have semaglutide, the key ingredient in Ozempic and Wegovy.
FBI issues safety warning about counterfeit versions of weight loss drug semaglutide
The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide, the active ingredient in Ozempic and Wegovy, two prescription medications used for weight loss.
Ireland’s Profits From Weight-Loss Drugs Draw Trump’s Attention
It leaves Ireland particularly exposed to Trump’s trade tariffs.  “We have lots of global supply chains that are operating ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
New York Post8d
We went blind after using weight-loss drugs like Ozempic and Mounjaro
Recent studies have shown an association between drugs such as Ozempic, Mounjaro and Wegovy — which have become phenomenally popular for weight loss — and an increased risk of NAION.
The Business Journals5d
Employers face pressure to add coverage of Ozempic, other weight-loss drugs
Businesses are facing pressure on multiple fronts to coverage popular weight-loss drugs. The situation is nearing a flash ...
Bengalureans take a shine to anti-obesity drugs
Weight loss injectables like Ozempic have gained popularity in Bengaluru, with patients sourcing them from abroad. The ...
Knowridge Science Report21h
This drug lowers blood sugar and body weight faster than other diabetes drugs
A new study has found that the diabetes drug tirzepatide helps people lower their blood sugar and lose weight more quickly ...
Scientists Discover Potential Ozempic Rival That Could Help People Lose Weight With Less Nausea
Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...